103 related articles for article (PubMed ID: 17053360)
1. On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
Flandre P; Costagliola D
AIDS; 2006 Oct; 20(16):2118-20. PubMed ID: 17053360
[TBL] [Abstract][Full Text] [Related]
2. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
[TBL] [Abstract][Full Text] [Related]
3. The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Maillard A; Chapplain JM; Tribut O; Bentué-Ferrer D; Tattevin P; Arvieux C; Michelet C; Ruffault A
J Clin Virol; 2007 Feb; 38(2):131-8. PubMed ID: 17208042
[TBL] [Abstract][Full Text] [Related]
4. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
Vercauteren J; Vandamme AM
Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
[TBL] [Abstract][Full Text] [Related]
5. The development of artificial neural networks to predict virological response to combination HIV therapy.
Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
[TBL] [Abstract][Full Text] [Related]
6. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
Schmidt B; Walter H; Zeitler N; Korn K
AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
[TBL] [Abstract][Full Text] [Related]
7. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
Assoumou L; Brun-Vézinet F; Cozzi-Lepri A; Kuritzkes D; Phillips A; Zolopa A; Degruttola V; Miller V; Costagliola D;
J Infect Dis; 2008 Aug; 198(4):470-80. PubMed ID: 18598191
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 genotypic drug-resistance interpretation algorithms need to include hypersusceptibility-associated mutations.
Wang K; Samudrala R; Mittler JE
J Infect Dis; 2004 Dec; 190(11):2055-6; author reply 2056. PubMed ID: 15529272
[No Abstract] [Full Text] [Related]
9. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks.
Wang D; Larder B
J Infect Dis; 2003 Sep; 188(5):653-60. PubMed ID: 12934180
[TBL] [Abstract][Full Text] [Related]
10. Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
Deforche K; Cozzi-Lepri A; Theys K; Clotet B; Camacho RJ; Kjaer J; Van Laethem K; Phillips A; Moreau Y; Lundgren JD; Vandamme AM;
Antivir Ther; 2008; 13(3):399-407. PubMed ID: 18572753
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.
de Mendoza C; Anta L; García F; Pérez-Elías MJ; Gutiérrez F; Llibre JM; Menéndez-Arias L; Dalmau D; Soriano V
AIDS Rev; 2009; 11(1):39-51. PubMed ID: 19290033
[TBL] [Abstract][Full Text] [Related]
12. Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
Marcelin AG; Flandre P; Molina JM; Katlama C; Yeni P; Raffi F; Antoun Z; Ait-Khaled M; Calvez V
Antimicrob Agents Chemother; 2008 Dec; 52(12):4251-7. PubMed ID: 18852278
[TBL] [Abstract][Full Text] [Related]
13. Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance.
Wang K; Jenwitheesuk E; Samudrala R; Mittler JE
Antivir Ther; 2004 Jun; 9(3):343-52. PubMed ID: 15259897
[TBL] [Abstract][Full Text] [Related]
14. Impact of HIV-1 pol diversity on drug resistance and its clinical implications.
Kantor R
Curr Opin Infect Dis; 2006 Dec; 19(6):594-606. PubMed ID: 17075337
[TBL] [Abstract][Full Text] [Related]
15. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
16. Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.
Masquelier B; Assoumou KL; Descamps D; Bocket L; Cottalorda J; Ruffault A; Marcelin AG; Morand-Joubert L; Tamalet C; Charpentier C; Peytavin G; Antoun Z; Brun-Vézinet F; Costagliola D;
J Antimicrob Chemother; 2008 Jun; 61(6):1362-8. PubMed ID: 18390885
[TBL] [Abstract][Full Text] [Related]
17. The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
Fox ZV; Geretti AM; Kjaer J; Dragsted UB; Phillips AN; Gerstoft J; Staszewski S; Clotet B; von Wyl V; Lundgren JD
AIDS; 2007 Oct; 21(15):2033-42. PubMed ID: 17885293
[TBL] [Abstract][Full Text] [Related]
18. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
[TBL] [Abstract][Full Text] [Related]
19. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
[TBL] [Abstract][Full Text] [Related]
20. Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.
Gianotti N; Galli L; Danise A; Hasson H; Boeri E; Lazzarin A; Castagna A
J Med Virol; 2006 Dec; 78(12):1537-41. PubMed ID: 17063520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
